A pilot trial of neoantigen DNA vaccine in combination with nivolumab/ipilimumab and prostvac in metastatic hormone-sensitive prostate cancer (mHSPC).

Shah, K; Ganapathy, A; Borkowski, A; Shah, N; Bansal, D; Beck, R; Knoche, EM; Picus, J; Reimers, MA; Roth, BJ; Gulley, JL; Schreiber, R; Pachynski, RK

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索